We Specialize In

Mr. Hurst is an entrepreneur that has driven R&D, go-to-market, and reimbursement strategies for biopharmaceutical, genomic, and molecular diagnostic products. He has played an active role in the molecular testing industry focusing on oncology, pharmacogenomics (PGx), and clinical services. Mr. Hurst has created presentations, product roadmaps, data-driven pricing, and reimbursement strategies by leading product development core teams and cross-functional teams for mission-critical projects.

By forging professional relationships with key-opinion leaders (KOLs), business partners, and consultants, he has launched several novel clinical genetic tests using multiple sequencing technology platforms. He has market experience in product development and commercialization of novel intellectual property (IP); including bench to bedside products for licensed IP from institutions such as Vanderbilt and John Hopkins.

With a target goal of creating a global scientific presence, Mr. Hurst has developed targeted messaging, product guides, market brochures, webinars, and videos for education and diverse customer segments. Through KOL and customer engagement at provider sites, company exhibitions, surveys, presentations and workshops, he has captured customer feedback and sales to drive product adoption, clinical services, and custom laboratory software development.

To achieve the fastest path to market for novel diagnostic products, Mr. Hurst played a critical role in leading multiple validation projects through CMS implementation guidelines for laboratory-developed tests (LDTs), including actionable report generation by working with KOLs and Laboratory Directors.

Mr. Barfield was born in Augusta, Georgia and lived in Aiken County during his early years. He served for four years in the U.S. Air Force. Bill has a Bachelor of Science in Business Economics and a Master’s in business. He began a State career in March, 1979, as a Budget Analyst in the health areas of the Department of Health and Environmental Control. Bill was Deputy Director for Maternity and Child Health Program Divisions at the Department of Health and Environmental Control for two years. In July, 1985, became the Budget Director for the Department of Mental Retardation. DMR later became the Department of Disabilities and Special Needs.In February, 1994, became the Deputy State Director for Fiscal Management at the Department of Disabilities and Special Needs. Bill retired as the Deputy State Director for Administration at the Department of Disabilities and Special Needs in June 2009.Since the fall of 2009, he has been a sole proprietor providing professional consulting regarding management, financial, and governmental matters based on three decades’ experience in these areas of expertise.In April 2016 became the Chief Financial Officer of Phi Life Sciences, LLC.